Canlyniadau Chwilio - Nicola Giuliani
- Dangos 1 - 20 canlyniadau o 49
- Ewch i'r Dudalen Nesaf
-
1
-
2
Angiogenic Switch in Multiple Myeloma gan Nicola Giuliani, Simona Colla, Vittorio Rizzoli
Cyhoeddwyd 2004Revisão -
3
-
4
-
5
-
6
Angiogenesis and Multiple Myeloma gan Nicola Giuliani, Paola Storti, Marina Bolzoni, Benedetta Dalla Palma, Sabrina Bonomini
Cyhoeddwyd 2011Artigo -
7
Do Human Myeloma Cells Directly Produce the Receptor Activator of Nuclear Factor κB Ligand (RANKL) or Induce RANKL in the Bone Marrow Microenvironment? gan Nicola Giuliani, Simona Colla, Vittorio Rizzoli, Sophie Barillé‐Nion, Régis Bataille
Cyhoeddwyd 2004Carta -
8
-
9
Mechanism of Action of Bortezomib and the New Proteasome Inhibitors on Myeloma Cells and the Bone Microenvironment: Impact on Myeloma-Induced Alterations of Bone Remodeling gan Fabrizio Accardi, Denise Toscani, Marina Bolzoni, Benedetta Dalla Palma, Franco Aversa, Nicola Giuliani
Cyhoeddwyd 2015Revisão -
10
-
11
-
12
The PAI-1 Gene Locus 4G/5G Polymorphism Is Associated With a Family History of Coronary Artery Disease gan Maurizio Margaglione, Giuseppe Cappucci, Donatella Colaizzo, Nicola Giuliani, Gennaro Vecchione, Elvira Grandone, Orazio Pennelli, Giovanni Di Minno
Cyhoeddwyd 1998Artigo -
13
Adenosine Generated in the Bone Marrow Niche Through a CD38-Mediated Pathway Correlates With Progression of Human Myeloma gan Alberto L. Horenstein, Valeria Quarona, Denise Toscani, Federica Costa, Antonella Chillemi, Vito Pistoia, Nicola Giuliani, Fabio Malavasi
Cyhoeddwyd 2016Artigo -
14
Production of Wnt Inhibitors by Myeloma Cells: Potential Effects on Canonical Wnt Pathway in the Bone Microenvironment gan Nicola Giuliani, Francesca Morandi, Sara Tagliaferri, Mirca Lazzaretti, Gaetano Donofrío, Sabrina Bonomini, Roberto Sala, Marcellina Mangoni, Vittorio Rizzoli
Cyhoeddwyd 2007Artigo -
15
Multiple myeloma-derived exosomes are enriched of amphiregulin (AREG) and activate the epidermal growth factor pathway in the bone microenvironment leading to osteoclastogenesis gan Stefania Raimondo, Laura Saieva, Emanuela Vicario, Marzia Pucci, Denise Toscani, Mauro Manno, Samuele Raccosta, Nicola Giuliani, Riccardo Alessandro
Cyhoeddwyd 2019Artigo -
16
-
17
Immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and the RANKL/OPG ratio in the myeloma microenvironment targeting the exp... gan Marina Bolzoni, Paola Storti, Sabrina Bonomini, Katia Todoerti, Daniela Guasco, Denise Toscani, Luca Agnelli, Antonino Neri, Vittorio Rizzoli, Nicola Giuliani
Cyhoeddwyd 2012Artigo -
18
Myeloma cells block RUNX2/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation gan Nicola Giuliani, Simona Colla, Francesca Morandi, Mirca Lazzaretti, Roberto Sala, Sabrina Bonomini, Maria Grano, Silvia Colucci, Mirija Svaldi, Vittorio Rizzoli
Cyhoeddwyd 2005Artigo -
19
PAI-1 Plasma Levels in a General Population Without Clinical Evidence of Atherosclerosis gan Maurizio Margaglione, Giuseppe Cappucci, Marina d’Addedda, Donatella Colaizzo, Nicola Giuliani, Gennaro Vecchione, Giulio Mascolo, Elvira Grandone, Giovanni Di Minno
Cyhoeddwyd 1998Artigo -
20
Offerynnau Chwilio:
Pynciau Perthynol
Medicine
Internal medicine
Multiple myeloma
Biology
Cancer research
Immunology
Chemistry
Bone marrow
Biochemistry
Receptor
Genetics
Cell biology
Gene
Endocrinology
In vitro
Oncology
Stem cell
Osteoclast
Bortezomib
Activator (genetics)
Lenalidomide
Surgery
Bone resorption
CD34
CD38
Osteoblast
RANKL
Molecular biology
Osteolysis
Osteoprotegerin